What Is the eGFR Decline in ADPKD After Stopping Tolvaptan?

If you stop taking tolvaptan, its active disease-slowing benefits will fade. Evidence shows that kidney function (measured by eGFR) declines faster and total kidney volume (TKV) grows more rapidly after stopping the medication compared to while you are taking it ^[1]. However, stopping the drug does not appear to cause an immediate “overshoot” or abrupt catch-up phenomenon where your kidneys suddenly get worse than they would have been if you had never taken the drug ^[1]. The time you gained while on the medication is not lost in a sudden rebound, but without the drug’s ongoing active protection, your kidneys will gradually return toward their expected, untreated rate of decline ^[1][2].

Why Are You Stopping? Liver Toxicity vs. Side Effects

Because tolvaptan carries a risk of serious liver injury, your prescriber will require regular liver-function blood tests while you take it ^[3]. Your next steps depend heavily on the reason you are stopping the medication:

• Stopping for Liver Concerns: If you are stopping due to abnormal liver tests or symptoms of liver injury, do not restart the medication on your own ^[3]. Tolvaptan-associated liver-test abnormalities generally improve after the drug is stopped, but restarting after suspected liver injury must only be done if explicitly directed by your specialist ^[4][5].
• Stopping for Aquaresis (Urination/Thirst): If you are considering stopping because the excessive urination or thirst is intolerable, discuss your options with your doctor first. Depending on your situation, they may suggest a temporary pause, a dose reduction, or changing the time you take your pills rather than stopping completely ^[6][7].

When to Contact Your Clinician Urgently

Do not wait for your next routine appointment if you develop any of the following:

• Possible liver injury symptoms: Unusual fatigue, loss of appetite, nausea, vomiting, right-upper-abdominal pain, dark urine, or yellowing of the skin or eyes.
• Signs of severe dehydration: Extreme dizziness upon standing, fainting, confusion, or an inability to keep fluids down due to vomiting or severe illness.

Follow your local prescribing instructions about holding your dose in these situations.

How Stopping Affects Kidney Function (eGFR)

Tolvaptan helps preserve kidney function by slowing the rate at which your eGFR (estimated glomerular filtration rate, a measure of how well your kidneys filter waste) drops ^[8][5]. When you stop the medication, research shows that the rate of eGFR decline accelerates again ^[1].

• In one large study population, patients taking tolvaptan lost an average of 1.89 points of eGFR per year. After stopping the drug, that decline sped up to an average of 4.94 points per year ^[1].

It is important to understand that these numbers are averages from a specific study population over a specific period, not a personal forecast for you. Your individual rate of decline depends on your age, baseline eGFR, genetics, and disease stage. Additionally, a single eGFR test right after stopping does not establish a new long-term trend, as eGFR can fluctuate based on hydration, illness, or laboratory variations.

How Stopping Affects Total Kidney Volume (TKV)

A key indirect measure of ADPKD progression and cyst burden is Total Kidney Volume (TKV). Tolvaptan is effective at slowing this growth while you take it ^[8]. When the drug is discontinued, your kidneys will likely begin to grow faster again.

• In a pooled analysis, the average annual kidney growth increased from about 5.15% per year while on the drug to 8.16% per year after stopping ^[1].

Like eGFR, these TKV figures are population averages. Furthermore, changes in TKV can look artificially dramatic if the MRI is measured using different techniques or by different radiologists ^[9]. Because of this, repeat TKV imaging is highly individualized and is not always required immediately after a treatment gap. Your doctor will order serial TKV imaging only when it will change your management plan, using consistent measurement methods ^[9].

Are the Past Benefits Erased?

It is common to worry that stopping means you endured the medication for nothing, or that your disease will suddenly surge forward. Current evidence has not shown an abrupt catch-up phenomenon ^[1][2].

The time you spent on tolvaptan effectively delayed your disease progression during that specific period ^[5][10]. However, this does not mean the prior benefit is permanently stored. The active disease-slowing effect fades when the drug leaves your system, and the rate of future progression generally moves back toward your expected untreated rate ^[1]. To maintain ongoing protection, the medication must be taken regularly as prescribed ^[11][8].

Moving Forward Without Tolvaptan

If you must permanently discontinue tolvaptan, you and your nephrologist can focus on other supportive strategies. While these are not direct substitutes for the disease-modifying effect of tolvaptan, they are essential for protecting your kidney and cardiovascular health:

• Individualized Blood Pressure Targets: Working with your clinician to reach a specific, personalized blood pressure goal (often using an ACE inhibitor or ARB medication) is critical to preserving kidney function.
• A New Hydration Plan: While on tolvaptan, you had to drink constantly to manage aquaresis ^[6]. After stopping, that intense aquaretic effect will fade. Do not continue to force excessive amounts of water without consulting your doctor, as overhydration can be harmful if you have advanced kidney, heart, or liver issues. Ask your clinician for a new, individualized fluid plan.
• Dietary Sodium Reduction: Keeping your salt intake low helps manage blood pressure and kidney workload.
• Individualized Monitoring: Your doctor will set a personalized schedule to monitor your eGFR, blood pressure, urine, and electrolytes to track your progression.